<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04735731</url>
  </required_header>
  <id_info>
    <org_study_id>DIAMANT-study</org_study_id>
    <nct_id>NCT04735731</nct_id>
  </id_info>
  <brief_title>Assessing the DIAphragM Before ANd After Endobronchial Valve Treatment</brief_title>
  <acronym>DIAMANT</acronym>
  <official_title>Assessing the DIAphragM Before ANd After Endobronchial Valve Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale:&#xD;
&#xD;
      The diaphragm is the principal respiratory muscle, which separates the thorax from the&#xD;
      abdomen. Hyperinflation of the lung places the diaphragm at a mechanical disadvantage,&#xD;
      shortens its operating length and changes the mechanical arrangement of costal and crural&#xD;
      components of the diaphragm and consequently decrease the tension that can be developed and&#xD;
      the amount of transdiaphragmatic pressure that can be produced. Reducing the lung&#xD;
      hyperinflation could improve the diaphragm function mechanically. One of the treatments to&#xD;
      reduces lung hyperinflation is the bronchoscopic treatment using endobronchial valves. To our&#xD;
      knowledge the change in diaphragm function after bronchoscopic endobronchial valve treatment&#xD;
      was never investigated.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
      To investigate the change in diaphragm function after bronchoscopic lung volume reduction&#xD;
      treatment with endobronchial valves (EBV).&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      Observational study in which the study population will be asked to perform some additional&#xD;
      test during regular visits for the bronchoscopic lung volume reduction treatment with valves.&#xD;
&#xD;
      Main study parameters: Change in diaphragm function 6 week after EBV treatment measured by&#xD;
      ultrasound. The main outcome will be diaphragm motion (difference between maximum in- and&#xD;
      expiration).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in diaphragm motion measured by ultrasound</measure>
    <time_frame>6 weeks</time_frame>
    <description>Change in diaphragm motion 6 week after EBV treatment measured by ultrasound.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Emphysema</condition>
  <arm_group>
    <arm_group_label>EBV-patients</arm_group_label>
    <description>Patients who are scheduled for a bronchoscopic lung volume reduction treatment using endobronchial valves</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Echography</intervention_name>
    <description>Echography of diaphragma and other respiratory muscles</description>
    <arm_group_label>EBV-patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe emphysema who undergo a bronchoscopic lung volume reduction treatment&#xD;
        with one-way endobronchial valves.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves&#xD;
&#xD;
          2. Patient read, understood and signed the Informed Consent Form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        There are no exclusion criteria for this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk-Jan Slebos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jorine Hartman, PhD</last_name>
    <phone>+31503619194</phone>
    <email>j.hartman@umcg.nl</email>
  </overall_contact>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 29, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>Dirk-Jan Slebos</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data can be shared on reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

